Tools for Practice Outils pour la pratique


#374 Vitamin D and Fracture Prevention: Not what it’s cracked up to be?


CLINICAL QUESTION
QUESTION CLINIQUE
Does vitamin D prevent fragility fractures?


BOTTOM LINE
RÉSULTAT FINAL
Vitamin D alone does not prevent fractures regardless of dose, vitamin D status or previous fracture. The combination of calcium and vitamin D might reduce the risk of total fractures from 11.5% to 10.9% and hip fractures from 1.8% to 1.5% over 9-84 months, but this benefit may be limited to women in long-term care. Adding calcium increases risk of renal calculi (2.1% to 2.5%).



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Eight systematic reviews1-8 of 7-36 randomized controlled trials (RCTs); 34,000-76,000 mostly community-dwelling women: some with previous fracture, established osteoporosis or metabolic bone disease, followed 9-84 months.
  • Vitamin D versus placebo/no treatment:
    • Total fracture:1-8 No difference.
    • Hip fracture:1-5,8 No difference. One systematic review7 (varying high doses) suggested slightly higher risk in women (1.2% versus 0.9%).
    • Total or hip fractures:
      • High dose (>800 IU): Three systematic reviews1,4,8 showed no difference, one7 showed increased risk (described above) and one6 showed benefit, but no absolute numbers reported.
      • Baseline vitamin D level <50 nmol/L1 or previous fracture:2 No difference.
  • Vitamin D-calcium combination versus placebo:
    • Total fracture: 10.9% versus 11.5% (placebo), number needed to treat (NNT)=167.2 Others showed similar.3,5,6 One systematic review did not report largest RCT.1
      • Removing two RCTs of women in long-term care: Results no longer statistically different.2
    • Hip fracture:2 1.5% versus 1.8% (placebo), NNT=333.
      • Two systematic reviews found similar; 3,5 one found no difference.8
    • Total or hip fracture:
      • Baseline vitamin D <50 nmol/L1 or previous fracture:1,2 No difference.
  • Adverse events:
    • Vitamin D alone: None.2
    • Combination: No difference in mortality or gastrointestinal effects;2 renal calculi increased (2.5% versus 2.1% placebo).7
  • Limitations: Disproportionate number of smaller positive studies, skewing results towards favouring vitamin D.2,4 Randomization process and concealment uncertain.2

CONTEXT
CONTEXTE
  • Calcium alone has no effect on the risk of total or hip fracture.1,8
  • Osteoporosis Canada: Supplementation with vitamin D and calcium is unlikely to have clinically important benefit if diet contains adequate calcium.9
  • Measuring vitamin D levels routinely is unnecessary. No RCTs have evaluated treating to a target vitamin D level to prevent fractures.10


Maureen Kennedy September 30, 2024

very useful information for everyday practice

James Livingstone September 30, 2024

Good information contrary to current conventional practice.


Latest Tools for Practice
Derniers outils pour la pratique

#374 Vitamin D and Fracture Prevention: Not what it’s cracked up to be?

Does vitamin D prevent fragility fractures?
Read Lire 0.25 credits available Crédits disponibles

#373 Strategies for initiating insulin in type 2 diabetes

What is the optimal initial insulin for patients with type 2 diabetes?
Read Lire 0.25 credits available Crédits disponibles

#372 Mission Slimpossible Part 2: Oral GLP-1 agonists for weight loss

Are oral GLP-1 agonists effective for weight loss?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Jennifer Young MD CCFP-EM
  • Émélie Braschi MD PhD

1. Zhao JG, Zeng XT, Wang J et al. JAMA. 2017 Dec 26; 318(24):2466-2482.

2. Avenell A, Mak JC, O'Connell D. Cochrane Database Syst Rev. 2014 Apr 14; 2014(4):CD000227.

3. Bolland MJ, Grey A, Gamble GD, et al. Lancet Diabetes Endocrinol. 2014 Apr; 2(4):307-320.

4. Bolland MJ, Grey A, Avenell A. Lancet Diabetes Endocrinol. 2018 Nov; 6(11):847-858.

5. Yao P, Bennett D, Mafham M. JAMA Netw Open. 2019 Dec 2; 2(12):e1917789.

6. Thanapluetiwong S, Chewcharat A, Takkavatakarn K, et al. Medicine (Baltimore). 2020 Aug 21; 99(34):e21506.

7. de Souza MM, Moraes Dantas RL, Leão Durães V, et al. J Gen Intern Med. 2024 Jul 12. DOI:10.1007/s11606-024-08933-1.

8. Khatri K, Kaur M, Dhir T, et al. Indian J Med Res. 2023 Jan; 158(1):5-16.

9. Morin SN, Feldman S, Funnell L, et al. CMAJ. 2023 Oct 10; 195(39):E1333-E1348.

10. Lindblad A, McCormack J, Garrison S. Vitamin D Levels: Vitamin Do or Vitamin Don’t. Tools for Practice #106. Available at https://cfpclearn.ca/tfp106/. Accessed on May 2, 2024.

Authors have no conflicts of interest to declare.